Pharmacokinetic interactions between antiepileptic drugs (AED) and direct oral anticoagulants (DOAC).

• Conditions: G40.9; I48.9; Epilepsy, unspecified; Atrial fibrillation and atrial flutter, unspecified

• Registration Number: DRKS00029398
• Lead Sponsor: Charité – Universitätsmedizin Berlin, Klinik für Neurologie, Klinische und Experimentelle Epileptologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

patients with existing comedication of DOAC and AED
- patients taking DOAC with new indication for AED
- patients taking DOAC without AED treatment
- all approved AEDs in monotherapy
- all approved DOACs

Exclusion Criteria

- patients with legal guardianship
- polytherapy of AED

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma concentrations of DOACs